Quantitative assessment of liver fat with magnetic resonance imaging and spectroscopy

Journal of Magnetic Resonance Imaging

Volumn 34, Issue 4, 2011, Pages 729-749

  Reeder, Scott B ^a,b   Cruite, Irene ^c   Hamilton, Gavin ^c   Sirlin, Claude B ^c  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

complex; fat quantification; fat fraction; hepatic steatosis; magnetic resonance imaging; magnetic resonance spectroscopy; magnitude

Indexed keywords

TRIACYLGLYCEROL;

CLINICAL DECISION MAKING; CLINICAL FEATURE; CYSTIC FIBROSIS; DIAGNOSTIC ACCURACY; ECHOGRAPHY; FATTY LIVER; GOLD STANDARD; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAABDOMINAL FAT; LIPID LIVER LEVEL; LIPODYSTROPHY; LIVER; LIVER BIOPSY; LIVER FAT; LIVER FIBROSIS; LIVER TOXICITY; NONALCOHOLIC FATTY LIVER; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PATIENT MONITORING; POINT RESOLVED SPECTROSCOPY; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; QUANTITATIVE ANALYSIS; RADIODIAGNOSIS; REVIEW; SCREENING; SENSITIVITY AND SPECIFICITY; SIGNAL NOISE RATIO; STIMULATED ECHO ACQUISITION MODE; VIRUS HEPATITIS; VOXEL BASED MORPHOMETRY;

DIAGNOSTIC IMAGING; FATTY LIVER; FATTY LIVER, ALCOHOLIC; FEMALE; HUMANS; LIVER; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; TOMOGRAPHY, X-RAY COMPUTED; ULTRASONOGRAPHY, DOPPLER;

EID: 80052996528     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.22580     Document Type: Review

References (95)

1. Adams LA, Lymp JF, St Sauver J, et al. The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology 2005; 129: 113-121. (Pubitemid 41002048)
2. Adams LA, Waters OR, Knuiman MW, Elliott RR, Olynyk JK,. NAFLD as a risk factor for the development of diabetes and the metabolic syndrome: an eleven-year follow-up study. Am J Gastroenterol 2009; 104: 861-867.
3. Dunn W, Xu R, Wingard DL, et al. Suspected nonalcoholic fatty liver disease and mortality risk in a population-based cohort study. Am J Gastroenterol 2008; 103: 2263-2271.
4. Fabbrini E, deHaseth D, Deivanayagam S, Mohammed BS, Vitola BE, Klein S,. Alterations in fatty acid kinetics in obese adolescents with increased intrahepatic triglyceride content. Obesity (Silver Spring) 2009; 17: 25-29. (Pubitemid 50310536)
5. Korenblat KM, Fabbrini E, Mohammed BS, Klein S,. Liver, muscle, and adipose tissue insulin action is directly related to intrahepatic triglyceride content in obese subjects. Gastroenterology 2008; 134: 1369-1375. (Pubitemid 351615354)
6. Lok AS, Everhart JE, Chung RT, et al. Evolution of hepatic steatosis in patients with advanced hepatitis C: results from the hepatitis C antiviral long-term treatment against cirrhosis (HALT-C) trial. Hepatology 2009; 49: 1828-1837.
7. Lok AS, Everhart JE, Chung RT, et al. Hepatic steatosis in hepatitis C: comparison of diabetic and nondiabetic patients in the hepatitis C antiviral long-term treatment against cirrhosis trial. Clin Gastroenterol Hepatol 2007; 5: 245-254. (Pubitemid 46223652)
8. Matteoni CA, Younossi ZM, Gramlich T, Boparai N, Liu YC, McCullough AJ,. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 1999; 116: 1413-1419. (Pubitemid 29258890)
9. Rubinstein E, Lavine JE, Schwimmer JB,. Hepatic, cardiovascular, and endocrine outcomes of the histological subphenotypes of nonalcoholic fatty liver disease. Semin Liver Dis 2008; 28: 380-385.
10. Sanyal AJ, Banas C, Sargeant C, et al. Similarities and differences in outcomes of cirrhosis due to nonalcoholic steatohepatitis and hepatitis C. Hepatology 2006; 43: 682-689.
11. Ekstedt M, Franzen LE, Mathiesen UL, et al. Long-term follow-up of patients with NAFLD and elevated liver enzymes. Hepatology 2006; 44: 865-873. (Pubitemid 46489550)
12. Clark JM, Diehl AM,. Defining nonalcoholic fatty liver disease: implications for epidemiologic studies. Gastroenterology 2003; 124: 248-250. (Pubitemid 36055357)
13. Ioannou GN,. Development and validation of a model predicting graft survival after liver transplantation. Liver Transpl 2006; 12: 1594-1606. (Pubitemid 44742538)
14. Szczepaniak LS, Nurenberg P, Leonard D, et al. Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population. Am J Physiol Endocrinol Metab 2005; 288: E462-468. (Pubitemid 40110657)
15. Ludwig J, Viggiano T, DB M, Oh B,. Nonalcoholic steatohepatitis: Mayo Clinic experience with a hitherto unnamed disease. Mayo Clin Proc 1980; 55: 434-438. (Pubitemid 10057164)
16. Angulo P, Keach JC, Batts KP, Lindor KD,. Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis. Hepatology 1999; 30: 1356-1362.
17. Gramlich T, Kleiner DE, McCullough AJ, Matteoni CA, Boparai N, Younossi ZM,. Pathologic features associated with fibrosis in nonalcoholic fatty liver disease. Hum Pathol 2004; 35: 196-199. (Pubitemid 38240902)
18. Guzman G, Brunt EM, Petrovic LM, Chejfec G, Layden TJ, Cotler SJ,. Does nonalcoholic fatty liver disease predispose patients to hepatocellular carcinoma in the absence of cirrhosis? Arch Pathol Lab Med 2008; 132: 1761-1766.
19. Schindhelm RK, Diamant M, Heine RJ,. Nonalcoholic fatty liver disease and cardiovascular disease risk. Curr Diab Rep 2007; 7: 181-187. (Pubitemid 46951915)
20. Targher G, Arcaro G,. Non-alcoholic fatty liver disease and increased risk of cardiovascular disease. Atherosclerosis 2007; 191: 235-240. (Pubitemid 46400718)
21. Angelico M,. Donor liver steatosis and graft selection for liver transplantation: a short review. Eur Rev Med Pharmacol Sci 2005; 9: 295-297. (Pubitemid 41387395)
22. Ploeg RJ, D'Alessandro AM, Knechtle SJ, et al. Risk factors for primary dysfunction after liver transplantation-a multivariate analysis. Transplantation 1993; 55: 807-813. (Pubitemid 23122053)
23. Yoong KF, Gunson BK, Neil DA, et al. Impact of donor liver microvesicular steatosis on the outcome of liver retransplantation. Transplant Proc 1999; 31: 550-551. (Pubitemid 29127569)
24. Busuttil RW, Tanaka K,. The utility of marginal donors in liver transplantation. Liver Transpl 2003; 9: 651-663. (Pubitemid 36874450)
25. Brunt EM, Janney CG, Di Bisceglie AM, Neuschwander-Tetri BA, Bacon BR,. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol 1999; 94: 2467-2474. (Pubitemid 29420675)
26. Marsman H, Matsushita T, Dierkhising R, et al. Assessment of donor liver steatosis: pathologist or automated software? Hum Pathol 2004; 35: 430-435. (Pubitemid 38507079)
27. Zaitoun AM, Al Mardini H, Awad S, Ukabam S, Makadisi S, Record CO,. Quantitative assessment of fibrosis and steatosis in liver biopsies from patients with chronic hepatitis C. J Clin Pathol 2001; 54: 461-465. (Pubitemid 32531096)
28. Bravo A, Sheth S, Chopra S,. Liver biopsy. N Engl J Med 2001; 344: 495-500. (Pubitemid 32164902)
29. Ratziu V, Charlotte F, Heurtier A, et al. Sampling variability of liver biopsy in nonalcoholic fatty liver disease. Gastroenterology 2005; 128: 1898-1906. (Pubitemid 40824701)
30. Emond MJ, Bronner MP, Carlson TH, Lin M, Labbe RF, Kowdley KV,. Quantitative study of the variability of hepatic iron concentrations. Clin Chem 1999; 45: 340-346. (Pubitemid 29114168)
31. Villeneuve JP, Bilodeau M, Lepage R, Cote J, Lefebvre M,. Variability in hepatic iron concentration measurement from needle-biopsy specimens. J Hepatol 1996; 25: 172-177. (Pubitemid 26276629)
32. Abdi W, Millan JC, Mezey E,. Sampling variability on percutaneous liver biopsy. Arch Intern Med 1979; 139: 667-669. (Pubitemid 10097795)
33. Baunsgaard P, Sanchez GC, Lundborg CJ,. The variation of pathological changes in the liver evaluated by double biopsies. Acta Pathol Microbiol Scand [A] 1979; 87: 51-57. (Pubitemid 9115110)
34. Bedossa P, Dargere D, Paradis V,. Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology 2003; 38: 1449-1457. (Pubitemid 37466971)
35. Labayle D, Chaput JC, Albuisson F, Buffet C, Martin E, Etienne JP,. [Comparison of the histological lesions in tissue specimens taken from the right and left lobe of the liver in alcoholic liver disease (author's transl).] Gastroenterol Clin Biol 1979; 3: 235-240. (Pubitemid 9192596)
36. Maharaj B, Maharaj RJ, Leary WP, et al. Sampling variability and its influence on the diagnostic yield of percutaneous needle biopsy of the liver. Lancet 1986; 1: 523-525. (Pubitemid 16138427)
37. Olsson R, Hagerstrand I, Broome U, et al. Sampling variability of percutaneous liver biopsy in primary sclerosing cholangitis. J Clin Pathol 1995; 48: 933-935.
38. Regev A, Berho M, Jeffers LJ, et al. Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Am J Gastroenterol 2002; 97: 2614-2618.
39. Charatcharoenwitthaya P, Lindor KD,. Role of radiologic modalities in the management of non-alcoholic steatohepatitis. Clin Liver Dis 2007; 11: 37-54, viii. (Pubitemid 46829975)
40. Mishra P, Younossi ZM,. Abdominal ultrasound for diagnosis of nonalcoholic fatty liver disease (NAFLD). Am J Gastroenterol 2007; 102: 2716-2717. (Pubitemid 350179334)
41. Saadeh S, Younossi ZM, Remer EM, et al. The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology 2002; 123: 745-750. (Pubitemid 34977081)
42. Mottin CC, Moretto M, Padoin AV, et al. The role of ultrasound in the diagnosis of hepatic steatosis in morbidly obese patients. Obes Surg 2004; 14: 635-637. (Pubitemid 38716583)
43. Graif M, Yanuka M, Baraz M, et al. Quantitative estimation of attenuation in ultrasound video images: correlation with histology in diffuse liver disease. Invest Radiol 2000; 35: 319-324. (Pubitemid 30395315)
44. Kodama Y, Ng CS, Wu TT, et al. Comparison of CT methods for determining the fat content of the liver. AJR Am J Roentgenol 2007; 188: 1307-1312. (Pubitemid 46668513)
45. Lee SW, Park SH, Kim KW, et al. Unenhanced CT for assessment of macrovesicular hepatic steatosis in living liver donors: comparison of visual grading with liver attenuation index. Radiology 2007; 244: 479-485.
46. Limanond P, Raman SS, Lassman C, et al. Macrovesicular hepatic steatosis in living related liver donors: correlation between CT and histologic findings. Radiology 2004; 230: 276-280. (Pubitemid 37549813)
47. Fazel R, Krumholz HM, Wang Y, et al. Exposure to low-dose ionizing radiation from medical imaging procedures. N Engl J Med 2009; 361: 849-857.
48. Birnbaum BA, Hindman N, Lee J, Babb JS,. Multi-detector row CT attenuation measurements: assessment of intra- and interscanner variability with an anthropomorphic body CT phantom. Radiology 2007; 242: 109-119. (Pubitemid 44956015)
49. Dixon WT,. Simple proton spectroscopic imaging. Radiology 1984; 153: 189-194. (Pubitemid 14043406)
50. Qayyum A, Goh JS, Kakar S, Yeh BM, Merriman RB, Coakley FV,. Accuracy of liver fat quantification at MR imaging: comparison of out-of-phase gradient-echo and fat-saturated fast spin-echo techniques-initial experience. Radiology 2005; 237: 507-511. (Pubitemid 41507887)
51. Glover GH, Schneider E,. Three-point Dixon technique for true water/fat decomposition with B0 inhomogeneity correction. Magn Reson Med 1991; 18: 371-383.
52. Xiang Q, An L,. Water-fat imaging with direct phase encoding. J Magn Reson Imaging 1997; 7: 1002-1015. (Pubitemid 28372875)
53. Ma J,. Breath-hold water and fat imaging using a dual-echo two-point Dixon technique with an efficient and robust phase-correction algorithm. Magn Reson Med 2004; 52: 415-419. (Pubitemid 39025289)
54. Reeder SB, Pineda AR, Wen Z, et al. Iterative decomposition of water and fat with echo asymmetry and least-squares estimation (IDEAL): application with fast spin-echo imaging. Magn Reson Med 2005; 54: 636-644. (Pubitemid 41233758)
55. Reeder SB, McKenzie CA, Pineda AR, et al. Water-fat separation with IDEAL gradient-echo imaging. J Magn Reson Imaging 2007; 25: 644-652. (Pubitemid 46355429)
56. Hernando D, Haldar JP, Sutton BP, Ma J, Kellman P, Liang ZP,. Joint estimation of water/fat images and field inhomogeneity map. Magn Reson Med 2008; 59: 571-580. (Pubitemid 351348228)
57. Hussain HK, Chenevert TL, Londy FJ, et al. Hepatic fat fraction: MR imaging for quantitative measurement and display-early experience. Radiology 2005; 237: 1048-1055. (Pubitemid 41636400)
58. Kovanlikaya A, Guclu C, Desai C, Becerra R, Gilsanz V,. Fat quantification using three-point Dixon technique: in vitro validation. Acad Radiol 2005; 12: 636-639. (Pubitemid 40603691)
59. Liu CY, McKenzie CA, Yu H, Brittain JH, Reeder SB,. Fat quantification with IDEAL gradient echo imaging: correction of bias from T (1) and noise. Magn Reson Med 2007; 58: 354-364. (Pubitemid 47267653)
60. Yu H, Shimakawa A, McKenzie CA, Brodsky E, Brittain JH, Reeder SB,. Multiecho water-fat separation and simultaneous R2* estimation with multifrequency fat spectrum modeling. Magn Reson Med 2008; 60: 1122-1134.
61. Kim H, Taksali SE, Dufour S, et al. Comparative MR study of hepatic fat quantification using single-voxel proton spectroscopy, two-point Dixon and three-point IDEAL. Magn Reson Med 2008; 59: 521-527. (Pubitemid 351348223)
62. Reeder SB, Wen Z, Yu H, et al. Multicoil Dixon chemical species separation with an iterative least-squares estimation method. Magn Reson Med 2004; 51: 35-45. (Pubitemid 38095700)
63. Bydder M, Yokoo T, Hamilton G, et al. Relaxation effects in the quantification of fat using gradient echo imaging. Magn Reson Imaging 2008; 26: 347-359.
64. Yu H, Shimakawa A, Hines CD, McKenzie CA, Hamilton G, Sirlin CB, Brittain JH, Reeder SB,. Combination of complex-based and magnitude-based multiecho water-fat separation for accurate quantification of fat-fraction. Magn Reson Med 2011; 66: 199-206.
65. Yu H, McKenzie CA, Shimakawa A, et al. Multiecho reconstruction for simultaneous water-fat decomposition and T2* estimation. J Magn Reson Imaging 2007; 26: 1153-1161. (Pubitemid 47548182)
66. Mitchell DG, Kim I, Chang TS, et al. Fatty liver. Chemical shift phase-difference and suppression magnetic resonance imaging techniques in animals, phantoms, and humans. Invest Radiol 1991; 26: 1041-1052.
67. Levenson H, Greensite F, Hoefs J, et al. Fatty infiltration of the liver: quantification with phase-contrast MR imaging at 1.5 T vs biopsy. AJR Am J Roentgenol 1991; 156: 307-312.
68. Kawamitsu H, Kaji Y, Ohara T, Sugimura K,. Feasibility of quantitative intrahepatic lipid imaging applied to the magnetic resonance dual gradient echo sequence. Magn Reson Med Sci 2003; 2: 47-50.
69. Rinella ME, McCarthy R, Thakrar K, et al. Dual-echo, chemical shift gradient-echo magnetic resonance imaging to quantify hepatic steatosis: implications for living liver donation. Liver Transpl 2003; 9: 851-856. (Pubitemid 36974953)
70. Pacifico L, Celestre M, Anania C, Paolantonio P, Chiesa C, Laghi A,. MRI and ultrasound for hepatic fat quantification: relationships to clinical and metabolic characteristics of pediatric nonalcoholic fatty liver disease. Acta Paediatr 2007; 96: 542-547. (Pubitemid 46466114)
71. Schuchmann S, Weigel C, Albrecht L, et al. Non-invasive quantification of hepatic fat fraction by fast 1.0, 1.5 and 3.0 T MR imaging. Eur J Radiol 2007; 62: 416-422. (Pubitemid 46783361)
72. Yoshimitsu K, Kuroda Y, Nakamuta M, et al. Noninvasive estimation of hepatic steatosis using plain CT vs. chemical-shift MR imaging: significance for living donors. J Magn Reson Imaging 2008; 28: 678-684.
73. Cowin GJ, Jonsson JR, Bauer JD, et al. Magnetic resonance imaging and spectroscopy for monitoring liver steatosis. J Magn Reson Imaging 2008; 28: 937-945.
74. Borra RJ, Salo S, Dean K, et al. Nonalcoholic fatty liver disease: rapid evaluation of liver fat content with in-phase and out-of-phase MR imaging. Radiology 2009; 250: 130-136.
75. McPherson S, Jonsson JR, Cowin GJ, et al. Magnetic resonance imaging and spectroscopy accurately estimate the severity of steatosis provided the stage of fibrosis is considered. J Hepatol 2009; 51: 389-397.
76. Fishbein MH, Gardner KG, Potter CJ, Schmalbrock P, Smith MA,. Introduction of fast MR imaging in the assessment of hepatic steatosis. Magn Reson Imaging 1997; 15: 287-293. (Pubitemid 27280484)
77. Guiu B, Petit JM, Loffroy R, et al. Quantification of liver fat content: comparison of triple-echo chemical shift gradient-echo imaging and in vivo proton MR spectroscopy. Radiology 2009; 250: 95-102.
78. Yokoo T, Bydder M, Hamilton G, et al. Nonalcoholic fatty liver disease: diagnostic and fat-grading accuracy of low-flip-angle multiecho gradient-recalled-echo MR imaging at 1.5 T. Radiology 2009; 251: 67-76.
79. O'Regan DP, Callaghan MF, Wylezinska-Arridge M, et al. Liver fat content and T2: simultaneous measurement by using breath-hold multiecho MR imaging at 3.0 T-feasibility. Radiology 2008; 247: 550-557.
80. d'Assignies G, Ruel M, Khiat A, et al. Noninvasive quantitation of human liver steatosis using magnetic resonance and bioassay methods. Eur Radiol 2009; 19: 2033-2040.
81. Reeder SB, Robson PM, Yu H, et al. Quantification of hepatic steatosis with MRI: the effects of accurate fat spectral modeling. J Magn Reson Imaging 2009; 29: 1332-1339.
82. Meisamy S, Hines C, Hamilton G, et al. Quantification of hepatic steatosis using T1 independent, T2* corrected MRI with spectral modeling of fat: a blinded comparison with MR spectroscopy. Radiology 2011; 258: 767-775.
83. Hamilton G, Middleton MS, Bydder M, et al. Effect of PRESS and STEAM sequences on magnetic resonance spectroscopic liver fat quantification. J Magn Reson Imaging 2009; 30: 145-152.
84. Hamilton G, Yokoo T, Bydder M, et al. In vivo characterization of the liver fat (1)H MR spectrum. NMR Biomed 2010 [Epub ahead of print].
85. Thomsen C, Becker U, Winkler K, Christoffersen P, Jensen M, Henriksen O,. Quantification of liver fat using magnetic resonance spectroscopy. Magn Reson Imaging 1994; 12: 487-495. (Pubitemid 24113193)
86. Bonkovsky HL, Jawaid Q, Tortorelli K, et al. Non-alcoholic steatohepatitis and iron: increased prevalence of mutations of the HFE gene in non-alcoholic steatohepatitis. J Hepatol 1999; 31: 421-429. (Pubitemid 29408723)
87. George DK, Goldwurm S, MacDonald GA, et al. Increased hepatic iron concentration in nonalcoholic steatohepatitis is associated with increased fibrosis. Gastroenterology 1998; 114: 311-318. (Pubitemid 28093538)
88. Chebrolu VV, Hines CD, Yu H, et al. Independent estimation of T2 for water and fat for improved accuracy of fat quantification. Magn Reson Med 2010; 63: 849-857.
89. Li Z, Graff C, Gmitro AF, et al. Rapid water and lipid imaging with T2 mapping using a radial IDEAL-GRASE technique. Magn Reson Med 2009; 61: 1415-1424.
90. Pineda N, Sharma P, Xu Q, Hu X, Vos M, Martin DR,. Measurement of hepatic lipid: high-speed T2-corrected multiecho acquisition at 1H MR spectroscopy-a rapid and accurate technique. Radiology 2009; 252: 568-576.
91. Hines CD, Yu H, Shimakawa A, McKenzie CA, Warner TF, Brittain JH, Reeder SB,. Quantification of hepatic steatosis with 3-T MR imaging: validation in ob/ob mice. Radiology 2010; 254: 119-128.
92. Bornert P, Keupp J, Eggers H, Aldefeld B,. Whole-body 3D water/fat resolved continuously moving table imaging. J Magn Reson Imaging 2007; 25: 660-665. (Pubitemid 46355431)
93. Hines CD, Yu H, Shimakawa A, McKenzie CA, Brittain JH, Reeder SB,. T1 independent, T2* corrected MRI with accurate spectral modeling for quantification of fat: validation in a fat-water-SPIO phantom. J Magn Reson Imaging 2009; 30: 1215-1222.
94. Hines CD, Yu H, Shimakawa A, et al. Quantification of hepatic steatosis with 3-T MR imaging: validation in ob/ob mice. Radiology 2010; 254: 119-128.
95. Yokoo T, Shiehmorteza M, Bydder M, et al. Spectrally-modeled hepatic fat quantification by multi-echo gradient-recalled-echo magnetic resonance imaging at 3.0T. In: Proc 17th Annual Meeting ISMRM, Honolulu; 2009.